Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of novel drug targets for mental disorders through genetic, colocalization, and network pharmacology approaches. | J Affect Disord | 2025 | 40784413 | PubTator, text mining | PubMed |
| Molecular insights into the bidirectional link between anxiety and COVID-19: a combined clinical and bioinformatics approach. | Front Psychiatry | 2025 | 40766923 | PubTator, text mining | PubMed |
| Progress of targeted FOX family therapy in ovarian cancer. | Front Pharmacol | 2025 | 40746724 | PubTator, text mining | PubMed |
| Restoration of Hair Luster via Novel Biomarker COL7A1 by Minoxidil, Caffeine, and Biotin. | Curr Issues Mol Biol | 2025 | 40699867 | PubTator, text mining | PubMed |
| CAR19-T/NK cell and circular aptamer-drug conjugate (ApDC) combination treatment increases immunotherapy efficacy. | Mol Cell Biochem | 2025 | 40652441 | PubTator, text mining | PubMed |
| High-Flux Chip for Sensitive Profiling of Small Extracellular Vesicle Proteins by Cas9/Switch-sgRNA Complex-Mediated Proximity Cleavage Assay. | Anal Chem | 2025 | 40618375 | PubTator, text mining | PubMed |
| Emerging Concepts of Targeted Protein Degrader Technologies via Lysosomal Pathways. | Int J Mol Sci | 2025 | 40565046 | PubTator, text mining | PubMed |
| Logic-Gated DNA Production Line for Cancer Cell Recognition and Intracellular Cascaded Gene Therapy. | Small | 2025 | 40556592 | PubTator, text mining | PubMed |
| Point-of-care detection of prostate cancer through surface protein profiling on extracellular vesicles using colorimetric 3D paper-based analytical devices. | Biosens Bioelectron | 2025 | 40540971 | PubTator, text mining | PubMed |
| Quantification of Wnt3a, Wnt5a and Wnt16 Binding to Multiple Frizzleds Under Physiological Conditions Using NanoBit/BRET. | Cells | 2025 | 40497984 | PubTator, text mining | PubMed |
| High-Throughput Multiplexed Quantification of Molecules by Aptamer Sequencing (Apt-seq) in Single Cells. | J Am Chem Soc | 2025 | 40488675 | PubTator, text mining | PubMed |
| Phototriggered LYTAC: Photoactive Bispecific Aptamer Chimera Enhances Targeted Degradation of Membrane Protein through Regulating Cell Autophagy. | J Am Chem Soc | 2025 | 40479736 | PubTator, text mining | PubMed |
| Property Characterization of Leucine-Integrated Oligonucleotide. | Anal Chem | 2025 | 40415219 | PubTator, text mining | PubMed |
| Click-constructed modular signal aptamer chimeras enable receptor-independent degradation of membrane proteins. | Proc Natl Acad Sci U S A | 2025 | 40388621 | PubTator, text mining | PubMed |
| RETRACTION: The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer. | Dis Markers | 2025 | 40371197 | PubTator, text mining | PubMed |
| The Wnt/β-catenin signaling pathway in colorectal cancer: mechanism and intervention of traditional Chinese medicine and chemical compound. | Front Pharmacol | 2025 | 40308773 | PubTator, text mining | PubMed |
| Enhanced "Off-On" Electrochemiluminescent Biosensor Based on a Multivalent Aptamer-Induced Spatial Confinement Strategy for Ultrasensitive Detection of Membrane Protein (PTK-7). | Anal Chem | 2025 | 40274545 | PubTator, text mining | PubMed |
| Multiplexed Detection of Tumor Markers and Discrimination of Cancer Cell Types by Laser Ablation-Dielectric Barrier Discharge Ionization-Mass Spectrometry. | Anal Chem | 2025 | 40262027 | PubTator, text mining | PubMed |
| A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer. | Lung Cancer | 2025 | 40086026 | PubTator, text mining | PubMed |
| Responsive DNA artificial cells for contact and behavior regulation of mammalian cells. | Nat Commun | 2025 | 40069211 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=4